Published in Clin J Am Soc Nephrol on March 01, 2008
HPV-related cancers after solid organ transplantation in the United States. Am J Transplant (2013) 1.03
Renal relevant radiology: use of ultrasound in kidney disease and nephrology procedures. Clin J Am Soc Nephrol (2014) 0.94
Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol (2015) 0.81
Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD. Clin J Am Soc Nephrol (2016) 0.79
Cancer incidence in kidney transplant recipients: a study protocol. BMC Cancer (2009) 0.78
Utility of Prostate Cancer Screening in Kidney Transplant Candidates. J Am Soc Nephrol (2015) 0.77
3q26 amplification is an effective negative triage test for LSIL: a historical prospective study. PLoS One (2012) 0.75
Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study. Clin J Am Soc Nephrol (2017) 0.75
Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study. Virol J (2012) 0.75
Donor-associated malignancy in kidney transplant patients. J Clin Invest (2013) 0.75
Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol (2010) 0.75
Not All Deaths in CKD Are from a Broken Heart. J Am Soc Nephrol (2015) 0.75
Cancer-related outcomes in kidney allograft recipients in England versus New York State: a comparative population-cohort analysis between 2003 and 2013. Cancer Med (2017) 0.75
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56
Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet (1990) 6.17
Screening for prostate cancer: recommendation and rationale. Ann Intern Med (2002) 6.04
Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88
Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29
Screening for breast cancer with mammography. Cochrane Database Syst Rev (2006) 5.19
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2001) 4.69
A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ (1998) 4.44
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol (2000) 4.17
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12
Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate (2004) 4.02
Screening for prostate cancer. Cochrane Database Syst Rev (2006) 3.46
Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med (1997) 3.24
Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. J Natl Cancer Inst (2002) 3.00
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut (2003) 2.96
American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin (2003) 2.91
Evidence-based disease management. JAMA (1997) 2.85
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst (2005) 2.82
Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer (1988) 2.61
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med (2006) 2.59
Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56
Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology (1989) 2.37
Screening for prostate cancer. American College of Physicians. Ann Intern Med (1997) 2.36
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Skin cancer prevention and screening: summary of the American College of Preventive Medicine's practice policy statements. CA Cancer J Clin (1998) 2.21
ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol (2003) 2.10
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA (1999) 1.96
Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol (2007) 1.95
A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care (2000) 1.94
Concern Early lung cancer action project: overall design and findings from baseline screening. Cancer (2000) 1.93
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ (1989) 1.84
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology (1995) 1.76
Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol (2004) 1.71
Screening for lung cancer. Cochrane Database Syst Rev (2004) 1.71
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl (2003) 1.71
Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidney Dis (2007) 1.70
Cost-effective screening strategies for colorectal cancer. J Public Health Med (1992) 1.67
Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant (2003) 1.66
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer (2000) 1.44
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer (2002) 1.41
Lung cancer screening: recommendation statement. Ann Intern Med (2004) 1.38
Screening for lung cancer: the guidelines. Chest (2003) 1.29
Sensitivity and specificity of first screen mammography in 15 NBSS centres. Can Assoc Radiol J (1988) 1.27
Screening for cervical cancer: recommendations and rationale. Am J Nurs (2003) 1.25
Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol (2003) 1.23
Screening for malignant melanoma: A cost-effectiveness analysis. J Am Acad Dermatol (1999) 1.11
The Mayo Lung Project: a perspective. Cancer (2000) 1.07
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. Urol Oncol (2004) 1.03
Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol (1999) 1.02
A cost utility analysis of mammography screening in Australia. Soc Sci Med (1992) 1.01
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant (2002) 1.00
Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst (1991) 0.98
Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med (1997) 0.98
Cost-effectiveness of mammographic screening in Australia. Aust J Public Health (1993) 0.97
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database Syst Rev (2003) 0.96
Mammographic breast cancer screening--a randomized trial in Malmö, Sweden. Maturitas (1985) 0.96
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant (2002) 0.95
Economic decision analysis model of screening for lung cancer. Eur J Cancer (2001) 0.94
Kidney biopsies taken before and after oral sodium phosphate bowel cleansing. Nephrol Dial Transplant (2006) 0.94
Multiple bilateral fibroadenomas of the breasts requiring mastectomy in a renal transplant patient. Clin Nephrol (2004) 0.94
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther (2004) 0.93
Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Aust N Z J Public Health (1996) 0.92
Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int (2004) 0.91
A randomised trial of population screening for melanoma. J Med Screen (2002) 0.91
Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis (2006) 0.91
Screening for breast cancer: recommendations and rationale. Am Fam Physician (2002) 0.90
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrol Dial Transplant (2002) 0.89
Screening for skin cancer. Am J Prev Med (2001) 0.88
Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients. Indian J Cancer (2003) 0.88
Could chest X-ray screening for lung cancer be cost-effective? Cancer (2000) 0.87
Pain and discomfort associated with mammography among urban low-income African-American women. J Community Health (2005) 0.83
Cost-effectiveness in the prevention of colorectal cancer. Gastroenterol Clin North Am (2002) 0.83
Acute renal failure following oral sodium phosphate bowel preparation in diabetes. Diabetes Care (2007) 0.82
Lung cancer screening with low-dose CT. Eur J Radiol (2003) 0.82
ACOG committee opinion. Routine cancer screening. Number 185, September 1997 (replaces no. 128, October 1993). Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet (1997) 0.81
ACS updates guideline for the early detection of cervical neoplasia and cancer. American Cancer Society. Am Fam Physician (2003) 0.80
Cervical cancer. Mass screening, incidence and mortality in Finland. Acta Obstet Gynecol Scand Suppl (1977) 0.80
Cost-effectiveness of rescreening conventionally prepared cervical smears by PAPNET testing. Acta Cytol (1997) 0.80
ACOG practice bulletin. Breast cancer screening. Number 42, April 2003. Int J Gynaecol Obstet (2003) 0.78
Early detection of prostate cancer in the ESRD population. Clin Nephrol (2004) 0.77
The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992. Cancer (1999) 0.77
Gastrointestinal blood loss in patients with chronic renal failure. Am J Kidney Dis (1982) 0.77
American Cancer Society issues redefined breast cancer screening guidelines. Iowa Med (2003) 0.76
Screening for skin cancer: recommendations and rationale. Am J Nurs (2002) 0.76
Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am J Kidney Dis (2006) 0.76
ACOG committee opinion. Routine cancer screening. Number 247, December 2000. Int J Gynaecol Obstet (2003) 0.76
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2012) 6.38
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis (2007) 5.84
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med (2009) 4.90
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23
Long-term survival of children with end-stage renal disease. N Engl J Med (2004) 4.10
Clinical trials in children. Lancet (2004) 3.97
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol (2004) 3.30
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med (2010) 3.18
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17
Measuring the quality of public open space using Google Earth. Am J Prev Med (2011) 2.11
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09
Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med (2004) 2.03
Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.88
The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol (2008) 1.87
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol (2002) 1.79
Chronic allograft nephropathy: current concepts and future directions. Transplantation (2006) 1.79
The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78
Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol (2007) 1.77
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Support interventions for caregivers of people with chronic kidney disease: a systematic review. Nephrol Dial Transplant (2008) 1.74
Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol (2005) 1.72
Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev (2011) 1.69
Risk factors for nocturnal enuresis in school-age children. J Urol (2009) 1.68
Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58
Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev (2011) 1.58
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55
4. Bedwetting and toileting problems in children. Med J Aust (2005) 1.54
Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken) (2013) 1.53
Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev (2011) 1.52
Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50
The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48
Factors influencing quality of life in children with urinary incontinence. J Urol (2011) 1.47
Interventions for bone disease in children with chronic kidney disease. Cochrane Database Syst Rev (2010) 1.47
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev (2009) 1.46
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44
Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation (2015) 1.43
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med (2008) 1.41
The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev (2012) 1.39
Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation (2014) 1.39
Sevelamer: a promising but unproven drug. Nephrol Dial Transplant (2007) 1.39
Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39